Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income 797 M817 M855 M511 M1.07 B461 M 2.9 B Non-Operating Income, Total 312 M-62 M139 M153 M408 M397 M 1.1 B Interest expense, net of interest capitalized 241 M248 M253 M263 M272 M269 M 1.06 B Non-Operating Income, excl. Interest Expenses 34 M-356 M-153 M-133 M93 M87 M -106 M Unusual income/expense 37 M46 M39 M23 M43 M41 M 146 M Pretax income 617 M726 M720 M311 M848 M398 M 2.28 B Equity in earnings 000——— — Taxes 28 M141 M98 M-4 M107 M64 M 265 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 589 M585 M622 M315 M741 M334 M 2.01 B Discontinued operations —————— — Net income 589 M585 M622 M315 M741 M334 M 2.01 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 589 M585 M622 M315 M741 M334 M 2.01 B Basic earnings per share (Basic EPS) 1.181.171.250.631.480.67 4.03 Diluted earnings per share (Diluted EPS) 1.181.171.240.631.480.67 4.02 Average basic shares outstanding 498 M499 M499 M499 M499 M498 M — Diluted shares outstanding 500 M500 M501 M501 M500 M499 M — EBITDA —————— — EBIT 797 M817 M855 M511 M1.07 B461 M 2.9 B Cost of revenue 1.51 B1.13 B1.44 B1.33 B1.84 B1.19 B 5.8 B Other cost of goods sold 1.19 B826 M1.13 B1.01 B1.51 B866 M 4.52 B Depreciation & amortization (cash flow) —————— —